QH103 Cell Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QH103 Cell Injection, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]